GU5.F Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Healthcare Pharmaceuticals Frankfurt Exchange
10.42 EUR
Close of Nov 13, 2026
1.41 2.03
Market cap
EUR 2.29B
P/E
8.3x
P/B
0.44x
ROE
8.5%
Dividend yield
6.75%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is GU5.F undervalued?

Graham number
Price10.42
Graham value25.78
Discount59.6%

GU5.F trades 59.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited fundamental analysis

No fundamental analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited yet.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and ch…

Full company profile